
Childhood Arthritis and Rheumatology Research Alliance
Mission
To unite the pediatric rheumatology community to drive research and transform the lives of children with rheumatic diseases.
Vision
A world where every child with rheumatic disease thrives.
Our Work
CARRA conducts and supports innovative and collaborative clinical and translational research that generates new knowledge and improves the lives of children and families affected by pediatric rheumatic disease.

Maintaining Research Excellence
CARRA continuously develops and maintains a scientific agenda that reflects existing expertise, building on knowledge, innovation, and resources both within and outside of medicine, to accelerate discovery. We encourage multi-disciplinary team science to promote collaboration across stakeholders, nurture broad engagement, and provide academic advancement opportunities.
We optimize engagement of patients and families, including individuals representing diverse backgrounds and perspectives, as research partners. At the same time, CARRA engages research committees and workgroups to advance our scientific priorities and foster pediatric rheumatology researchers.

Engagement & Collaborations
CARRA proactively engages with its members, research partners and other key stakeholders.
The organization maintains – while seeking to grow – a multi-faceted portfolio of opportunities to engage CARRA’s diverse community and membership, as well as developing a leadership pipeline.
CARRA seeks to match member engagement with their research interests and capabilities.
We will continue to collaborate with the Arthritis Foundation and other key partners including science-based industry; other non-profit organizations and foundations and stakeholders in a mutually beneficial fashion.

Impact for Progress
Becoming a member, partnering or collaborating with CARRA optimizes progress in pediatric rheumatic diseases research.
On a platform of organizational diversity, equity, inclusion and accessibility in our research, processes, and people work with clear metrics and mechanisms to equitably and successfully capture data from people everywhere.
Members, patients/caregivers, staff, and partners are informed, meaningfully engaged, and experience incomparable value from their participation with CARRA, as well as strengthens CARRA’s capacity to realize its mission.
Our Members
A strong and growing CARRA membership amplifies our ability to conduct collaborative research to prevent, treat, and cure pediatric rheumatic diseases, enhancing the prospects for a world free of limitations from pediatric rheumatic diseases.
Apply for research grants and leadership positions to advance your career. Connect and collaborate with members by joining today.
Become a MemberLatest from our blog
-
Searching for Answers, Finding Purpose: An Athlete’s Journey with Juvenile Arthritis – by Shaw McGrath
When people support medical research, it can sometimes be hard to see where that support goes. Research can sound distant from everyday life, like something that happens in labs, hospitals, meetings, or data systems far away from the patient. But for a kid living with a pediatric rheumatic disease, research is not distant at all.…
-
Our Scleroderma Journey to Advocacy, Research, and Hope – by Pamela Pour
Imagine experiencing a family vacation of a lifetime in the Dubai desert, under the glistening moon lit starry night. Surrounded by bright colored blanketed chairs and sparkling belly dances as your family eagerly awaited fresh chicken kebabs to be served. A little girl walking by, stops next to my daughter, reaches out and touches her…
-
CARRA Membership Spotlight: Andrew Kung, MD
Andrew Kung is a current third-year pediatric rheumatology fellow at Penn State Children’s Health. His interest in pediatric rheumatology first developed during residency while caring for patients with systemic juvenile idiopathic arthritis (sJIA) and macrophage activation syndrome. One experience in particular helped solidify his path into the field. After suggesting the diagnosis of systemic JIA…


